Communicative Participation and Quality of Life in Pretreatment Oral and Oropharyngeal Head and Neck Cancer.


Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 16 9 2020
medline: 2 7 2021
entrez: 15 9 2020
Statut: ppublish

Résumé

To determine how communicative participation is affected in patients with oral and oropharyngeal head and neck cancers (HNCs) pretreatment and whether communication function predicts HNC-specific quality of life (QOL) before treatment, beyond known demographic, medical, psychosocial, and swallowing predictors. Cross-sectional study. Tertiary care academic medical center. Eighty-seven patients with primary oral (40.2%) or oropharyngeal (59.8%) HNC were recruited prior to treatment. T stage, tumor site, and p16 status were extracted from medical records. Demographic and patient-reported measures were obtained. Communicative participation was measured using the Communicative Participation Item Bank (CPIB) General short form. A hierarchical regression analysis included demographic, medical, psychosocial, and functional measures of swallowing and communication as predictors; the University of Washington Quality of Life (UW-QOL v4) composite score was the predicted variable. Median (SD) baseline CPIB scores were 71.0 (11.83); patients with oral cancers reported worse scores. A final sequential hierarchical regression model that included all variables explained 71% of variance in QOL scores. Tumor site, T stage, and p16 status accounted for 28% of variance ( Pretreatment communication predicted QOL and was negatively affected in some oral and oropharyngeal patients with HNC.

Identifiants

pubmed: 32928035
doi: 10.1177/0194599820950718
pmc: PMC7933052
mid: NIHMS1647578
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

616-623

Subventions

Organisme : NCI NIH HHS
ID : R01 CA177635
Pays : United States

Références

Laryngoscope. 2011 Jun;121(6):1212-8
pubmed: 21541945
Head Neck. 2013 Jun;35(6):779-87
pubmed: 22715128
Laryngoscope. 2016 May;126(5):1108-13
pubmed: 26542529
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):772-8
pubmed: 15708256
Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):380-4
pubmed: 19380361
Oral Oncol. 2012 Jun;48(6):547-53
pubmed: 22289636
Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):489-92
pubmed: 27681744
Clin Otolaryngol. 2005 Apr;30(2):169-75
pubmed: 15839870
Head Neck. 2014 Jan;36(1):47-54
pubmed: 23559533
Arch Otolaryngol Head Neck Surg. 2012 Feb;138(2):123-33
pubmed: 22248560
Cancer. 2014 Mar 15;120(6):840-7
pubmed: 24352973
Head Neck. 2000 Jan;22(1):6-11
pubmed: 10585599
Multivariate Behav Res. 2000 Jul 1;35(3):321-64
pubmed: 26745335
Cancer Treat Rev. 2009 Aug;35(5):417-24
pubmed: 19481871
Head Neck. 2008 Jul;30(7):868-74
pubmed: 18302270
Disabil Rehabil. 2008;30(6):425-33
pubmed: 17943516
J Otolaryngol Head Neck Surg. 2017 Sep 4;46(1):56
pubmed: 28870248
Laryngoscope. 2000 Mar;110(3 Pt 3):4-7
pubmed: 10718406
J Speech Lang Hear Res. 2009 Oct;52(5):1302-20
pubmed: 19717652
Head Neck. 2015 Mar;37(3):425-39
pubmed: 24318166
Ann Otol Rhinol Laryngol. 2014 Apr;123(4):257-64
pubmed: 24671481
Oral Oncol. 2007 Nov;43(10):1034-42
pubmed: 17307019
Head Neck. 2016 Apr;38 Suppl 1:E1955-61
pubmed: 26714043
Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1849-55
pubmed: 26071622
Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1495-505
pubmed: 20589505
Otolaryngol Head Neck Surg. 2012 May;146(5):739-45
pubmed: 22275190
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Speech Lang Hear Res. 2013 Aug;56(4):1190-208
pubmed: 23816661
Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):870-6
pubmed: 11448365
Otolaryngol Head Neck Surg. 2018 Aug;159(2):266-273
pubmed: 29558245
Am J Speech Lang Pathol. 2011 Nov;20(4):269-87
pubmed: 21813820
Int J Lang Commun Disord. 2018 Nov;53(6):1059-1077
pubmed: 30039920
JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1145-1151
pubmed: 27442853
Am J Speech Lang Pathol. 2006 Nov;15(4):307-20
pubmed: 17102143
Dysphagia. 2011 Jun;26(2):155-70
pubmed: 20623305
Head Neck. 1999 Aug;21(5):394-401
pubmed: 10402518

Auteurs

Cara Sauder (C)

Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA.

Mara Kapsner-Smith (M)

Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA.

Carolyn Baylor (C)

Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA.
Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, USA.

Kathryn Yorkston (K)

Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA.
Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, USA.

Neal Futran (N)

Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA.

Tanya Eadie (T)

Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA.
Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH